Report shows growth in neuromuscular disease therapies

29 January 2025

The global neuromuscular disease therapeutics market is projected to grow by $13.73 billion between 2025 and 2029, according to a recent report from Technavio. This represents a compound annual growth rate (CAGR) of 14.6% over the forecast period.

Key drivers of this growth include the approval of novel treatments and advancements in therapy technology. However, the high cost of these therapeutics remains a challenge for patients.

Leading companies in this sector are investing in innovative treatments to address unmet medical needs. Major players include AbbVie (NYSE: ABBV), Aquestive Therapeutics (Nasdaq: AQST), argenx (Nasdaq: ARGX), AstraZeneca (LSE: AZN), Biogen (Nasdaq: BIIB), and others.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology